1985
DOI: 10.1079/pns19850035
|View full text |Cite
|
Sign up to set email alerts
|

Inositol phospholipid and phosphatidic acid metabolism in response to membrane receptor activation

Abstract: The status of myo-inositol ( Fig. r(a)) as a vitamin is uncertain since some human tissues can synthesize it from glucose-6-phosphate. Eagle et a1. (1957), however, showed that it was an essential growth factor for many human cells in tissue culture. The concentration required for optimum growth was higher than would be expected of a typical vitamin, suggesting a metabolic role for inositol. It now seems clear that this role involves the phospholipids which contain inositol, phosphatidylinositol (PtdIns), phos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1987
1987
2013
2013

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 30 publications
0
2
0
Order By: Relevance
“…At that time, PI4,5P 2 was thought to only serve as an intermediate in the PI cycle . Early studies identified a role for PI4,5P 2 as a precursor of other signaling molecules, such as inositol trisphosphate (IP 3 ) and diacylglycerol (DAG) . In the 1980s, the role of PI4,5P 2 as a precursor was further expanded via the discovery that PI4,5P 2 could be used as substrate for PI3K to produce phosphatidylinositol 3,4,5‐trisphosphate (PI3,4,5P 3 ) .…”
Section: Introductionmentioning
confidence: 99%
“…At that time, PI4,5P 2 was thought to only serve as an intermediate in the PI cycle . Early studies identified a role for PI4,5P 2 as a precursor of other signaling molecules, such as inositol trisphosphate (IP 3 ) and diacylglycerol (DAG) . In the 1980s, the role of PI4,5P 2 as a precursor was further expanded via the discovery that PI4,5P 2 could be used as substrate for PI3K to produce phosphatidylinositol 3,4,5‐trisphosphate (PI3,4,5P 3 ) .…”
Section: Introductionmentioning
confidence: 99%
“…Stimulation of many tissues with a number of agonists has been shown to result in a rapid turnover of phosphoinositides (Michell, 1975;Michell et al, 1981;Berridge, 1984;Hawthorne, 1985). This enhanced metabolism occurs not only in response to hormone stimulation, but also in cell lines stimulated with growth factors such as platelet derived growth factor (Berridge et al, 1984;Hasegawa-Sasaki, 1985), in T-lymphocytes stimulated with mitogenic lectins (Fisher & Mueller, 1968;Hui & Harmony, 1980;Hasegawa-Sasaki & Sasaki, 1983;Taylor et al, 1984) and in B-lymphocytes stimulated with anti-Ig antibodies (Maino et al, 1975;Guy et al, 1985;Coggeshall & Cambier, 1984;Bijsterbosch et al, 1985).…”
Section: Introductionmentioning
confidence: 99%